糖尿病神经病变特征:中央与下涡区角膜神经纤维进行性丢失
该纵向研究纳入30例糖尿病患者和19名年龄匹配健康对照,评估基线与随访1至8年间的角膜神经形态及神经病变指标。糖尿病患者随访期间角膜神经分支密度、纤维长度、下涡长度及平均神经纤维长度显著下降,提示下涡区角膜神经丢失尤为明显。
要点
- 糖尿病患者随访中角膜神经分支密度、纤维长度、下涡长度及平均神经纤维长度显著降低。
- 下涡区角膜神经长度下降幅度较大,提示该区域神经丢失更明显。
- 角膜神经纤维密度、神经病变残疾评分、冷感知阈值及腓总运动神经传导速度无显著变化。
核心结论
- 糖尿病患者存在角膜神经丢失证据,随访期间下涡区尤为明显。
研究设计与样本
- 纵向观察研究,纳入30例糖尿病患者(年龄54.08±15.86岁,病程23.95±14.2年,HbA1c 7.51±1.37)和19名年龄匹配健康对照(年龄49.47±13.25岁),在基线和随访1至8年时评估神经病变指标及角膜神经形态。
主要发现
- 糖尿病患者随访期间角膜神经分支密度显著降低(57.72±30.08 vs. 44.04±23.69;P=0.02)。
- 角膜神经纤维长度显著降低(21.77±5.19 vs. 15.65±4.7;P<0.0001)。
- 下涡长度显著降低(24.69±8.67 vs. 14.23±6.13;P<0.0001)。
- 平均角膜神经纤维长度显著降低(23.26±5.53 vs. 15.09±4.48;P<0.0001)。
- 热感知阈值显著降低(43.56±4.43 vs. 40.78±4.93;P=0.01),振动感知阈值显著升高(12.9±8.96 vs. 13.78±8.99;P=0.02)。
关键数值与推荐
- 角膜神经纤维密度无显著变化(27.12±8.2 vs. 25.43±7.11;P=0.2)。
- 神经病变残疾评分无显著变化(3.38±3.35 vs. 2.61±2.8;P=0.08)。
- 冷感知阈值无显著变化(17.7±10.59 vs. 22.45±9.23;P=0.06)。
- 腓总运动神经传导速度无显著变化(42.4±4.21 vs. 42.16±6.3;P=0.2)。
临床怎么用
- 在糖尿病周围神经病变随访中,可关注角膜神经形态尤其是下涡区长度变化,作为神经损伤进展的观察指标。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: We hypothesized that longitudinal changes in corneal nerve morphology would differ between the central cornea and inferior whorl in relation to other measures of diabetic neuropathy. METHODS: Thirty patients with diabetes (age: 54.08 ± 15.86, duration: 23.95 ± 14.2, HbA1c: 7.51 ± 1.37) and 19 age-matched healthy controls (age: 49.47 ± 13.25) underwent assessment of neuropathy disability score (NDS), vibration perception threshold (VPT), cold (CPT) and warm (WPT) perception thresholds, peroneal motor nerve conduction velocity (PMNCV), corneal nerve fiber density (CNFD), branch density (CNBD), fiber length (CNFL), inferior whorl length (IWL), and the average of CNFL and IWL (ANFL) at baseline and after 1 to 8 years. RESULTS: In patients with diabetes, between baseline and follow-up, there was a significant reduction in CNBD (57.72 ± 30.08 vs. 44.04 ± 23.69; P = 0.02), CNFL (21.77 ± 5.19 vs. 15.65 ± 4.7; P < 0.0001), IWL (24.69 ± 8.67 vs. 14.23 ± 6.13; P < 0.0001), ANFL (23.26 ± 5.53 vs. 15.09 ± 4.48; P < 0.0001), and WPT (43.56 ± 4.43 vs. 40.78 ± 4.93; P = 0.01), and an increase in VPT (12.9 ± 8.96 vs. 13.78 ± 8.99; P = 0.02). There was no significant change in CNFD (27.12 ± 8.2 vs. 25.43 ± 7.11; P = 0.2), NDS (3.38 ± 3.35 vs. 2.61 ± 2.8; P = 0.08), CPT (17.7 ± 10.59 vs. 22.45 ± 9.23; P = 0.06), or PMNCV (42.4 ± 4.21 vs. 42.16 ± 6.3; P = 0.2). CONCLUSIONS: There is evidence of corneal nerve loss in patients with diabetes, particularly at the inferior whorl during follow-up.
引用
- Ferdousi M, Kalteniece A, Petropoulos I, et al. Diabetic Neuropathy Is Characterized by Progressive Corneal Nerve Fiber Loss in the Central and Inferior Whorl Regions. Invest Ophthalmol Vis Sci. 2020. PMID: 32232351. doi:10.1167/iovs.61.3.48
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。